Publication Information

{'id': 'https://openalex.org/W1553263682', 'doi': 'https://doi.org/10.1046/j.1365-2125.2003.01778.x', 'title': 'Population pharmacokinetics of levosimendan in patients with congestive heart failure', 'display_name': 'Population pharmacokinetics of levosimendan in patients with congestive heart failure', 'publication_year': 2003, 'publication_date': '2003-05-12', 'ids': {'openalex': 'https://openalex.org/W1553263682', 'doi': 'https://doi.org/10.1046/j.1365-2125.2003.01778.x', 'mag': '1553263682', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/12814448', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/1884248'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1046/j.1365-2125.2003.01778.x', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2125.2003.01778.x', 'source': {'id': 'https://openalex.org/S13842274', 'display_name': 'British Journal of Clinical Pharmacology', 'issn_l': '0306-5251', 'issn': ['0306-5251', '1365-2125'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2125.2003.01778.x', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5011289806', 'display_name': 'E. Niclas Jonsson', 'orcid': 'https://orcid.org/0000-0002-2615-0280'}, 'institutions': [{'id': 'https://openalex.org/I123387679', 'display_name': 'Uppsala University', 'ror': 'https://ror.org/048a87296', 'country_code': 'SE', 'type': 'education', 'lineage': ['https://openalex.org/I123387679']}], 'countries': ['SE'], 'is_corresponding': False, 'raw_author_name': 'E. Niclas Jonsson', 'raw_affiliation_strings': ['Division of Pharmacokinetics and Drug Therapy, Uppsala University, Uppsala, Sweden.'], 'affiliations': [{'raw_affiliation_string': 'Division of Pharmacokinetics and Drug Therapy, Uppsala University, Uppsala, Sweden.', 'institution_ids': ['https://openalex.org/I123387679']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5058993133', 'display_name': 'Saila Antila', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210118237', 'display_name': 'Orion Corporation (Finland)', 'ror': 'https://ror.org/0296s4x19', 'country_code': 'FI', 'type': 'company', 'lineage': ['https://openalex.org/I4210118237']}], 'countries': ['FI'], 'is_corresponding': False, 'raw_author_name': 'Saila Antila', 'raw_affiliation_strings': ['Orion Corporation, Orion-Pharma Research and Development, Espoo, Finland, and'], 'affiliations': [{'raw_affiliation_string': 'Orion Corporation, Orion-Pharma Research and Development, Espoo, Finland, and', 'institution_ids': ['https://openalex.org/I4210118237']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5035996923', 'display_name': 'Lynn McFadyen', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I95023434', 'display_name': 'University of KwaZulu-Natal', 'ror': 'https://ror.org/04qzfn040', 'country_code': 'ZA', 'type': 'education', 'lineage': ['https://openalex.org/I95023434']}], 'countries': ['ZA'], 'is_corresponding': False, 'raw_author_name': 'Lynn McFadyen', 'raw_affiliation_strings': ['University of Durban – Westville Durban South Africa'], 'affiliations': [{'raw_affiliation_string': 'University of Durban – Westville Durban South Africa', 'institution_ids': ['https://openalex.org/I95023434']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5066773313', 'display_name': 'Lasse Lehtonen', 'orcid': 'https://orcid.org/0000-0002-3443-3838'}, 'institutions': [{'id': 'https://openalex.org/I4210118237', 'display_name': 'Orion Corporation (Finland)', 'ror': 'https://ror.org/0296s4x19', 'country_code': 'FI', 'type': 'company', 'lineage': ['https://openalex.org/I4210118237']}], 'countries': ['FI'], 'is_corresponding': False, 'raw_author_name': 'Lasse Lehtonen', 'raw_affiliation_strings': ['Orion Corporation, Orion-Pharma Research and Development, Espoo, Finland, and'], 'affiliations': [{'raw_affiliation_string': 'Orion Corporation, Orion-Pharma Research and Development, Espoo, Finland, and', 'institution_ids': ['https://openalex.org/I4210118237']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5070310610', 'display_name': 'Mats O. Karlsson', 'orcid': 'https://orcid.org/0000-0003-1258-8297'}, 'institutions': [{'id': 'https://openalex.org/I123387679', 'display_name': 'Uppsala University', 'ror': 'https://ror.org/048a87296', 'country_code': 'SE', 'type': 'education', 'lineage': ['https://openalex.org/I123387679']}], 'countries': ['SE'], 'is_corresponding': False, 'raw_author_name': 'Mats O. Karlsson', 'raw_affiliation_strings': ['Division of Pharmacokinetics and Drug Therapy, Uppsala University, Uppsala, Sweden.'], 'affiliations': [{'raw_affiliation_string': 'Division of Pharmacokinetics and Drug Therapy, Uppsala University, Uppsala, Sweden.', 'institution_ids': ['https://openalex.org/I123387679']}]}], 'institution_assertions': [], 'countries_distinct_count': 3, 'institutions_distinct_count': 3, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 4330, 'currency': 'USD', 'value_usd': 4330, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 2.271, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 38, 'citation_normalized_percentile': {'value': 0.930567, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 90, 'max': 91}, 'biblio': {'volume': '55', 'issue': '6', 'first_page': '544', 'last_page': '551'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10198', 'display_name': 'Heart Failure Treatment and Management', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10198', 'display_name': 'Heart Failure Treatment and Management', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12876', 'display_name': 'Potassium and Related Disorders', 'score': 0.9839, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10598', 'display_name': 'Cardiac pacing and defibrillation studies', 'score': 0.9798, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/nonmem', 'display_name': 'NONMEM', 'score': 0.92462623}, {'id': 'https://openalex.org/keywords/levosimendan', 'display_name': 'Levosimendan', 'score': 0.7814864}, {'id': 'https://openalex.org/keywords/concomitant', 'display_name': 'Concomitant', 'score': 0.6044099}, {'id': 'https://openalex.org/keywords/population-pharmacokinetics', 'display_name': 'Population Pharmacokinetics', 'score': 0.54375607}], 'concepts': [{'id': 'https://openalex.org/C2776239304', 'wikidata': 'https://www.wikidata.org/wiki/Q6954915', 'display_name': 'NONMEM', 'level': 3, 'score': 0.92462623}, {'id': 'https://openalex.org/C139254425', 'wikidata': 'https://www.wikidata.org/wiki/Q1332167', 'display_name': 'Volume of distribution', 'level': 3, 'score': 0.7842248}, {'id': 'https://openalex.org/C2777335384', 'wikidata': 'https://www.wikidata.org/wiki/Q162541', 'display_name': 'Levosimendan', 'level': 3, 'score': 0.7814864}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.77940464}, {'id': 'https://openalex.org/C2777707475', 'wikidata': 'https://www.wikidata.org/wiki/Q422222', 'display_name': 'Digoxin', 'level': 3, 'score': 0.7723329}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.7104947}, {'id': 'https://openalex.org/C2908647359', 'wikidata': 'https://www.wikidata.org/wiki/Q2625603', 'display_name': 'Population', 'level': 2, 'score': 0.6355726}, {'id': 'https://openalex.org/C2778198053', 'wikidata': 'https://www.wikidata.org/wiki/Q181754', 'display_name': 'Heart failure', 'level': 2, 'score': 0.6108879}, {'id': 'https://openalex.org/C2779384505', 'wikidata': 'https://www.wikidata.org/wiki/Q17007513', 'display_name': 'Concomitant', 'level': 2, 'score': 0.6044099}, {'id': 'https://openalex.org/C3020755252', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Population pharmacokinetics', 'level': 3, 'score': 0.54375607}, {'id': 'https://openalex.org/C44249647', 'wikidata': 'https://www.wikidata.org/wiki/Q208498', 'display_name': 'Confidence interval', 'level': 2, 'score': 0.48406735}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.34710908}, {'id': 'https://openalex.org/C164705383', 'wikidata': 'https://www.wikidata.org/wiki/Q10379', 'display_name': 'Cardiology', 'level': 1, 'score': 0.34473443}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.34040725}, {'id': 'https://openalex.org/C99454951', 'wikidata': 'https://www.wikidata.org/wiki/Q932068', 'display_name': 'Environmental health', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D002316', 'descriptor_name': 'Cardiotonic Agents', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D006333', 'descriptor_name': 'Heart Failure', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D006835', 'descriptor_name': 'Hydrazones', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D011724', 'descriptor_name': 'Pyridazines', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D000319', 'descriptor_name': 'Adrenergic beta-Antagonists', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000319', 'descriptor_name': 'Adrenergic beta-Antagonists', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D002316', 'descriptor_name': 'Cardiotonic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D002316', 'descriptor_name': 'Cardiotonic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002316', 'descriptor_name': 'Cardiotonic Agents', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D004077', 'descriptor_name': 'Digoxin', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D004077', 'descriptor_name': 'Digoxin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004311', 'descriptor_name': 'Double-Blind Method', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006333', 'descriptor_name': 'Heart Failure', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006835', 'descriptor_name': 'Hydrazones', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D006835', 'descriptor_name': 'Hydrazones', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D006835', 'descriptor_name': 'Hydrazones', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007262', 'descriptor_name': 'Infusions, Intravenous', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011724', 'descriptor_name': 'Pyridazines', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D011724', 'descriptor_name': 'Pyridazines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D011724', 'descriptor_name': 'Pyridazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077464', 'descriptor_name': 'Simendan', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1046/j.1365-2125.2003.01778.x', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2125.2003.01778.x', 'source': {'id': 'https://openalex.org/S13842274', 'display_name': 'British Journal of Clinical Pharmacology', 'issn_l': '0306-5251', 'issn': ['0306-5251', '1365-2125'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc1884248', 'pdf_url': 'https://europepmc.org/articles/pmc1884248?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884248', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/12814448', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1046/j.1365-2125.2003.01778.x', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2125.2003.01778.x', 'source': {'id': 'https://openalex.org/S13842274', 'display_name': 'British Journal of Clinical Pharmacology', 'issn_l': '0306-5251', 'issn': ['0306-5251', '1365-2125'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.78}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 24, 'referenced_works': ['https://openalex.org/W1525774039', 'https://openalex.org/W1550111394', 'https://openalex.org/W1556535974', 'https://openalex.org/W162506935', 'https://openalex.org/W1934572726', 'https://openalex.org/W1963642334', 'https://openalex.org/W1983477070', 'https://openalex.org/W1987376468', 'https://openalex.org/W2000876750', 'https://openalex.org/W2005170762', 'https://openalex.org/W2038229351', 'https://openalex.org/W2052832524', 'https://openalex.org/W2062780672', 'https://openalex.org/W2066118369', 'https://openalex.org/W2066464642', 'https://openalex.org/W2066996342', 'https://openalex.org/W2078187227', 'https://openalex.org/W2127139759', 'https://openalex.org/W2161035745', 'https://openalex.org/W2230049830', 'https://openalex.org/W2397481525', 'https://openalex.org/W2404799624', 'https://openalex.org/W2415978798', 'https://openalex.org/W4255368688'], 'related_works': ['https://openalex.org/W2990725098', 'https://openalex.org/W2429926177', 'https://openalex.org/W2340916786', 'https://openalex.org/W2172185836', 'https://openalex.org/W2142247990', 'https://openalex.org/W2091496519', 'https://openalex.org/W2088883133', 'https://openalex.org/W2031104234', 'https://openalex.org/W2021574530', 'https://openalex.org/W1553263682'], 'abstract_inverted_index': {'Aims': [0], 'The': [1, 58, 74, 190, 234], 'aim': [2], 'of': [3, 12, 35, 106, 116, 134, 149, 172, 183, 185, 205, 223, 238, 269, 282, 295], 'this': [4, 241], 'study': [5], 'was': [6, 77, 88, 99, 119, 164, 193], 'to': [7, 27, 138, 166, 195, 246], 'characterize': [8], 'the': [9, 71, 84, 102, 110, 113, 117, 131, 155, 158, 220, 263, 266, 283, 293], 'population': [10, 235], 'pharmacokinetics': [11, 236, 294], 'levosimendan': [13, 47, 127, 239], 'in': [14, 56, 70, 79, 240, 252, 272], 'patients': [15, 55, 256], 'with': [16, 46, 141, 257], 'heart': [17, 259], 'failure': [18], '(NYHA': [19], 'grades': [20], 'III': [21], 'and': [22, 24, 32, 37, 104, 130, 151, 179, 198, 202, 219, 255, 265, 288], 'IV)': [23], 'its': [25], 'relationship': [26], 'demographic': [28], 'factors,': [29], 'disease': [30], 'severity': [31], 'concomitant': [33, 147], 'use': [34, 148], 'digoxin': [36, 150, 287], 'β‐blocking': [38, 152, 289], 'agents.': [39], 'Methods': [40], 'Data': [41], 'from': [42], 'two': [43], 'efficacy': [44], 'studies': [45], 'administered': [48], 'by': [49, 101, 211, 225, 249, 277], 'intravenous': [50], 'infusion': [51], 'were': [52, 60, 136, 244], 'combined': [53], '(190': [54], 'total).': [57], 'data': [59], 'analysed': [61], 'using': [62], 'a': [63, 91, 161, 168, 180], 'nonlinear': [64], 'mixed‐effects': [65], 'modelling': [66], 'approach': [67], 'as': [68], 'implemented': [69], 'NONMEM': [72], 'program.': [73], 'model': [75, 87, 118, 124], 'development': [76], 'done': [78], 'three': [80], 'sequential': [81], 'steps.': [82], 'First': [83], 'best': [85, 125], 'structural': [86], 'determined': [89], '(e.g.': [90], 'one‐,': [92], 'two‐': [93], 'or': [94], 'three‐compartment': [95], 'pharmacokinetic': [96], 'model).': [97], 'This': [98], 'followed': [100], 'identification': [103], 'incorporation': [105], 'important': [107], 'covariates': [108], 'into': [109], 'model.': [111], 'Lastly': [112], 'stochastic': [114], 'part': [115], 'refined.': [120], 'Results': [121], 'A': [122], 'two‐compartment': [123], 'described': [126], 'pharmacokinetics.': [128, 156], 'Clearance': [129], 'central': [132, 181, 203, 221, 267], 'volume': [133, 182, 204, 222, 268], 'distribution': [135, 184, 224], 'found': [137], 'increase': [139], 'linearly': [140], 'bodyweight.': [142], 'No': [143], 'other': [144, 284], 'covariates,': [145, 285], 'including': [146, 286], 'agents,': [153, 290], 'influenced': [154, 262, 292], 'In': [157], 'final': [159], 'model,': [160], '76‐kg': [162], 'patient': [163, 242], 'estimated': [165, 194], 'have': [167], 'clearance': [169, 201, 210, 264], '±': [170, 174, 187], 's.e.': [171], '13.3': [173], '0.4': [175], 'l': [176], 'h': [177], '−1': [178], '16.8': [186], '0.79': [188], 'l.': [189], 'interindividual': [191], 'variability': [192], 'be': [196], '39%': [197], '60%': [199], 'for': [200, 276], 'distribution,': [206, 270], 'respectively.': [207], 'Weight': [208], 'changed': [209], '1.5%': [212], '[95%': [213], 'confidence': [214], 'interval': [215], '(CI)': [216], '0.9%,': [217], '2.1%]': [218], '0.9%': [226], '(95%': [227], 'CI': [228], '0.5%,': [229], '1.3%)': [230], 'per': [231], 'kg.': [232], 'Conclusions': [233], 'parameters': [237], 'group': [243], 'comparable': [245], 'those': [247], 'obtained': [248], 'traditional': [250], 'methods': [251], 'healthy': [253], 'volunteers': [254], 'mild': [258], 'failure.': [260], 'Bodyweight': [261], 'which': [271], 'practice': [273], 'is': [274], 'accounted': [275], 'weight': [278], 'adjusting': [279], 'doses.': [280], 'None': [281], 'significantly': [291], 'levosimendan.': [296]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1553263682', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2023, 'cited_by_count': 2}, {'year': 2022, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 2}, {'year': 2018, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 1}, {'year': 2013, 'cited_by_count': 2}], 'updated_date': '2024-12-09T08:02:13.880581', 'created_date': '2016-06-24'}